Thank You 2023 Sponsors and Exhibitors!

-

 

Thank You Sponsors & Exhibitors


The 52nd Annual Scientific Meeting of the International Society for Experimental Hematology meeting is taking place now in New York City, United States. The exciting program (https://www.iseh.org/ISEH2023) includes career and technology sessions, as well as talks and poster presentations from trainees, new investigators and leaders in the field.
On behalf of the ISEH Board of Directors, volunteers and staff, we'd like to thank our 2023 sponsors and exhibitors, seen below. We hope to see you all again in 2024!


Funding for this conference was made possible (in part) by R13HL170705 from the National Heart Lung and Blood Institute (NHLBI). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

 

This program is supported by an independent medical education grant from Pfizer.

Platinum

 

Gold

 

Silver

 

Bronze

Educational Supporters

 
 

Comments

Post a Comment

Popular posts from this blog

Transition from academia to industry: An interview with Elizabeth Paik

-
Image
We have all read many articles about the possible career choices of a scientist. The usual dilemma is between industry and academia. We have talked about this in previous blogs but the more information we get the easier it is to make a wise choice. Of course we all have opinions about the pros and cons of such a choice but what I always find best is to ask people who have experienced both. That is why I turned to an old colleague and friend, Elizabeth Paik, and asked her some questions regarding her experiences in both academia and industry. Can you describe to us your scientific career? I started my career at Harvard Medical School, as a graduate student in Dr. Len Zon's laboratory. My thesis work focused on understanding a role of CDX transcription factors during embryonic hematopoiesis. Through ChIP-seq, knockdown and overexpression studies in zebrafish, I showed CDX transcription factors control expression of hematopoietic transcription factors - SCL and LMO2. Towards the...
Read more

ISEH 2024 Society Award Winners

-
Image
On behalf of the Awards Committee, ISEH would like to congratulate the recipients of the 2024 ISEH Society Awards which will be presented at the ISEH 53rd Annual Scientific Meeting . Donald Metcalf Award Winner - Emmanuelle Passegué The 2024 Donald Metcalf Award goes to Dr. Emmanuelle Passegué for her outstanding work in the fields of normal and malignant hematopoietic stem cell biology. Dr. Passegué, Alumni Professor of Genetics & Development and Director of the Columbia Stem Cell Initiative (CSCI) at Columbia University Irving Medical Center in New York city, receives the highest honor bestowed by the Society for her distinguished work as an outstanding scientist, leader, and role model.  Dr. Passegué grew up in France, and after PhD studies at the Collège de France in Paris she went on to postdoctoral research, first with Dr. Erwin Wagner at the Institute of Molecular Pathology in Vienna and with Dr. Irv. Weissman at Stanford University. In 2005, she started her own independ...
Read more

Lab Spotlight: Vanuytsel Lab

-
Image
  Each month, Simply Blood spotlights a lab contributing to the fields of hematology, immunology, stem cell research, cell and gene therapies, and more. Get to know groups doing cutting edge research from around the world! This month, we are featuring the Vanuytsel Lab which is based out of the Center for Regenerative Medicine, Boston University. How long has your lab been open and who is in your lab currently? The lab opened in July 2023 and currently consists of a lab manager, a PhD student, a postdoc and three undergraduate researchers. What is the overarching research goal for your group? Our lab studies concepts at the intersection of hematopoietic development, stem cell biology and sickle cell disease. We are trying to gain an in-depth understanding of engraftment potential and how that is orchestrated during development so that we can harness those insights to improve stem cell engraftment in the context of gene therapy and stem cell transplantations. What we learn from stu...
Read more